Video

Dr. McKay on Adapting Treatment for Patients With Cancer in COVID-19 Era

Author(s):

Rana R. McKay, MD

Rana R. McKay, MD, discusses adapting treatment for patients with cancer during the coronavirus disease 2019 pandemic.

Rana R. McKay, MD, assistant professor of medicine and medical oncologist at the University of California, San Diego, discusses adapting treatment for patients with cancer during the coronavirus disease 2019 (COVID-19) pandemic.

Despite the widespread impact of COVID-19 on the world, limited data regarding the impact of the virus on treatment patterns in oncology have emerged, says McKay. Instead, treatment decisions for patients with cancer have predominantly been based on indirect scientific data, anecdotal evidence, and expert opinions.

Initial reports regarding COVID-19 appear to show that patients with cancer are more susceptible to the complications of the virus in terms of mortality and morbidity, concludes McKay.

Related Videos
Julia Rotow, MD, clinical director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute; assistant professor, medicine, Harvard Medical School
Joshua K. Sabari, MD, assistant professor, Department of Medicine, New York University Grossman School of Medicine; director, High Reliability Organization Initiatives, Perlmutter Cancer Center
Alastair Thompson, BSc, MBChB, MD, FRCS
C. Ola Landgren, MD, PhD
Sara M. Tolaney, MD, MPH
Adam M. Brufsky, MD, PhD, FACP
Justin M. Watts, MD
Sara M. Tolaney, MD, MPH
Leah Backhus, MD, MPH, FACS, professor, University Medical Line, Cardiothoracic Surgery, co-director, Thoracic Surgery Clinical Research Program, associate program director, Thoracic Track, CT Surgery Residency Training Program, Thelma and Henry Doelger Professor of Cardiovascular Surgery, Stanford Medicine; chief, Thoracic Surgery, VA Palo Alto
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Medical Oncology, director, Center for Thoracic Cancers, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Related Content
Paul G. Kluetz, MD
May 9th 2023

Decentralization Efforts Could Engage Community Oncologists

Jefferson Faculty Highlight COVID-19-Induced Disparities in Older Patients With Cancer
June 6th 2022

Jefferson Faculty Highlight COVID-19-Induced Disparities in Older Patients With Cancer

Electra D. Paskett, PhD
March 24th 2023

Delays in Cancer Screenings Due to COVID-19 May Result in Trend Toward Excess Deaths

Abid Accounts for the Efficacy of a Third SARS-CoV-2 Vaccine Among Transplant, CAR T-Cell, and BiTE Recipients
June 2nd 2022

Abid Accounts for the Efficacy of a Third SARS-CoV-2 Vaccine Among Transplant, CAR T-Cell, and BiTE Recipients

Maurie Markman, MD
October 26th 2022

Time Required to Address Scientific Questions Generates an Information Dilemma

Mili Arora, MD
July 8th 2022

In the Trenches With the Fellows